MCID: NRR001
MIFTS: 48

Neuroretinitis

Categories: Eye diseases, Neuronal diseases

Aliases & Classifications for Neuroretinitis

MalaCards integrated aliases for Neuroretinitis:

Name: Neuroretinitis 12 15 74
Juxtapapillary Focal Retinitis and Retinochoroiditis 12 74
Retinitis 45 74
Focal Retinitis and Retinochoroiditis, Juxtapapillary 12
Papilloretinitis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:10176
MeSH 45 D012173
ICD10 34 H30.9

Summaries for Neuroretinitis

MalaCards based summary : Neuroretinitis, also known as juxtapapillary focal retinitis and retinochoroiditis, is related to retinal hemangioblastoma and optic disk drusen. An important gene associated with Neuroretinitis is EXTL3 (Exostosin Like Glycosyltransferase 3). The drugs Azithromycin and Prednisone have been mentioned in the context of this disorder. Affiliated tissues include heart, breast and brain, and related phenotypes are endocrine/exocrine gland and hematopoietic system

Wikipedia : 77 Cat-scratch disease (CSD) is an infectious disease that results from a scratch or bite of a cat.... more...

Related Diseases for Neuroretinitis

Diseases related to Neuroretinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1912)
# Related Disease Score Top Affiliating Genes
1 retinal hemangioblastoma 33.1 CA2 VEGFA CD274
2 optic disk drusen 31.5 UBL4A VEGFA
3 retinal artery occlusion 30.4 ACE VEGFA
4 cancer-associated retinopathy 30.4 RCVRN VEGFA
5 relapsing-remitting multiple sclerosis 29.8 AQP4 IFNB1 MOG
6 multiple sclerosis 29.8 AQP4 CTLA4 IFNB1 MOG
7 myelitis 29.7 AQP4 MOG
8 acute mountain sickness 29.5 ACE VEGFA
9 demyelinating disease 29.5 AQP4 IFNB1 MOG
10 central nervous system disease 29.5 AQP4 IFNB1 MOG
11 autoimmune optic neuritis 29.4 AQP4 DPYSL5 MOG RCVRN
12 nervous system disease 29.1 ACE AQP4 IFNB1 MOG VEGFA
13 optic nerve disease 29.0 AQP4 DPYSL5 IFNB1 MOG UBL4A
14 retinitis pigmentosa 3 12.5
15 retinitis pigmentosa 27 12.4
16 retinitis pigmentosa 12 12.4
17 doyne honeycomb retinal dystrophy 12.4
18 retinitis pigmentosa 9 12.4
19 retinitis pigmentosa 2 12.4
20 retinitis pigmentosa 11 12.4
21 retinitis pigmentosa 4 12.4
22 retinitis pigmentosa 1 12.4
23 retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities 12.4
24 retinitis pigmentosa 28 12.4
25 retinitis pigmentosa 13 12.4
26 retinitis pigmentosa 17 12.4
27 retinitis pigmentosa 30 12.4
28 retinitis pigmentosa 18 12.4
29 late-onset retinal degeneration 12.4
30 retinitis pigmentosa 51 12.4
31 retinitis pigmentosa 55 12.4
32 retinitis pigmentosa 45 12.4
33 retinal disease 12.4
34 cytomegalovirus retinitis 12.3
35 retinal vascular occlusion 12.3
36 central retinal artery occlusion 12.3
37 neuropathy, ataxia, and retinitis pigmentosa 12.3
38 retinitis pigmentosa 7 12.3
39 infantile cerebellar-retinal degeneration 12.3
40 retinitis pigmentosa 50 12.3
41 posterior column ataxia with retinitis pigmentosa 12.3
42 retinal arteries, tortuosity of 12.3
43 retinitis pigmentosa 10 12.3
44 retinitis pigmentosa 41 12.3
45 retinitis pigmentosa 67 12.3
46 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 12.3
47 vasculopathy, retinal, with cerebral leukodystrophy 12.3
48 retinitis pigmentosa 38 12.3
49 retinitis pigmentosa 14 12.3
50 retinitis pigmentosa 46 12.3

Graphical network of the top 20 diseases related to Neuroretinitis:



Diseases related to Neuroretinitis

Symptoms & Phenotypes for Neuroretinitis

MGI Mouse Phenotypes related to Neuroretinitis:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.87 ACE AQP4 CA2 CTLA4 EXTL3 TNFRSF10A
2 hematopoietic system MP:0005397 9.86 ACE AQP4 CD274 CTLA4 IFNB1 MOG
3 homeostasis/metabolism MP:0005376 9.85 ACE AQP4 CA2 CD274 CTLA4 EXTL3
4 immune system MP:0005387 9.61 ACE AQP4 CA2 CD274 CTLA4 IFNB1
5 no phenotypic analysis MP:0003012 9.1 AQP4 CD274 IFNB1 TNFRSF10A UBL4A VEGFA

Drugs & Therapeutics for Neuroretinitis

Drugs for Neuroretinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 458)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 447043
2
Prednisone Approved, Vet_approved Phase 4,Phase 3 53-03-2 5865
3
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Not Applicable 137-58-6 3676
4
Dopamine Approved Phase 4,Not Applicable 62-31-7, 51-61-6 681
5
Esketamine Approved, Investigational Phase 4 33643-46-8
6
Ketamine Approved, Vet_approved Phase 4,Phase 1 6740-88-1 3821
7
Gabapentin Approved, Investigational Phase 4,Phase 3,Not Applicable 60142-96-3 3446
8
Droperidol Approved, Vet_approved Phase 4 548-73-2 3168
9
Bupivacaine Approved, Investigational Phase 4,Not Applicable 2180-92-9, 38396-39-3 2474
10
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Early Phase 1 437-38-7 3345
11
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
12
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
13
Tetracycline Approved, Vet_approved Phase 4 60-54-8 5353990
14
Doxycycline Approved, Investigational, Vet_approved Phase 4,Not Applicable 564-25-0 54671203
15
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
16
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
17
Aluminum hydroxide Approved, Investigational Phase 4 21645-51-2
18
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
19
Imipramine Approved Phase 4 50-49-7 3696
20
Pregabalin Approved, Illicit, Investigational Phase 4,Not Applicable 148553-50-8 5486971
21
Sirolimus Approved, Investigational Phase 4,Phase 2,Not Applicable 53123-88-9 46835353 6436030 5284616
22
Morphine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 57-27-2 5288826
23
Furosemide Approved, Vet_approved Phase 4,Phase 1 54-31-9 3440
24
Clozapine Approved Phase 4 5786-21-0 2818
25
Zinc Approved, Investigational Phase 4 7440-66-6 32051
26
Insulin Detemir Approved Phase 4 169148-63-4 5311023
27
4-Aminopyridine Approved Phase 4 504-24-5 1727
28
Caffeine Approved Phase 4,Not Applicable 58-08-2 2519
29
Metformin Approved Phase 4,Phase 2,Phase 1 657-24-9 14219 4091
30
Levonorgestrel Approved, Investigational Phase 4,Not Applicable 17489-40-6, 797-63-7 13109
31
Tamoxifen Approved Phase 4 10540-29-1 2733526
32
Paclitaxel Approved, Vet_approved Phase 4 33069-62-4 36314
33
Piperacillin Approved Phase 4 66258-76-2 43672
34
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
35
Tazobactam Approved Phase 4 89786-04-9 123630
36
Capsaicin Approved Phase 4 404-86-4 1548943
37
Ticagrelor Approved Phase 4 274693-27-5 9871419
38
Methylnaltrexone Approved Phase 4 83387-25-1, 916055-93-1 6603824
39
Ethanol Approved Phase 4,Phase 2,Phase 1,Not Applicable 64-17-5 702
40
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
41
carbamide peroxide Approved Phase 4 124-43-6
42
Rifampicin Approved Phase 4,Phase 3,Phase 2 13292-46-1 5381226 5458213
43
Rifapentine Approved, Investigational Phase 4,Phase 2 61379-65-5 6323497
44
Isoniazid Approved, Investigational Phase 4,Phase 3,Phase 2 54-85-3 3767
45
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-28-2 5757
46
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Not Applicable 28014-46-2
47
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
48
Remifentanil Approved Phase 4 132875-61-7 60815
49
Haloperidol Approved Phase 4 52-86-8 3559
50
chenodeoxycholic acid Approved Phase 4 474-25-9 10133

Interventional clinical trials:

(show top 50) (show all 469)
# Name Status NCT ID Phase Drugs
1 Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction Unknown status NCT02484105 Phase 4
2 The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease Unknown status NCT01469702 Phase 4 prednison and azithromycin;prednison, azithromycin;prednison, Azenil
3 Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy Unknown status NCT00209885 Phase 4 Gabapentin;S-ketamine;Lidocaine;Droperidol
4 Optimal Multimodal Analgesia in Abdominal Hysterectomy Unknown status NCT00209872 Phase 4 Gabapentin;Lidocaine;S-ketamine
5 Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair Unknown status NCT01326039 Phase 4 bupivacaine;saline
6 SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents Unknown status NCT00714545 Phase 4
7 Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomized, Single Blind, Controlled Study of Satisfaction and Safety. Unknown status NCT02226328 Phase 4 Propofol sedation;Midazolam and Fentanyl sedation
8 Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Unknown status NCT01661985 Phase 4 Azithromycin;Doxycycline;lymecycline
9 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
10 Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis Unknown status NCT01119014 Phase 4 Aripiprazole;Quetiapine
11 Imipramine and Pregabalin Combination in Painful Polyneuropathy Unknown status NCT01047488 Phase 4 Imipramine;Pregabalin;Imipramine, pregabalin;Placebo
12 Comparative Study on Self-adhesive Mesh for Open Inguinal Hernia Repair Unknown status NCT00960011 Phase 4
13 Santyl vs. Sharp Debridement of Diabetic Foot Wounds Completed NCT01056198 Phase 4 Santyl
14 The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. Completed NCT02625103 Phase 4 Clozapine
15 The SORT OUT IX STEMI OCT Trial Recruiting NCT02915107 Phase 4
16 Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass. Completed NCT01308554 Phase 4 Placebo: sterile normal saline;Marcaine
17 Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients Completed NCT00742976 Phase 4 Insulin Detemir; Insulin Insulatard;Insulin Detemir, Insulin Insulatard
18 Resistance Training and Amino Pyridine in Multiple Sclerosis Completed NCT02143167 Phase 4 SR-fampridine;Placebo
19 FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra Completed NCT01656148 Phase 4 Fampridine-SR
20 Effects of NSK-SD (Nattokinase) on Blood Pressure Completed NCT02886507 Phase 4
21 The Effect of Caffeine in Elderly Citizen Following Eight Hour Abstinence From Caffeine Containing Drinks & Foods Completed NCT01048515 Phase 4 Caffeine
22 Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy Completed NCT01934088 Phase 4 Propofol;Midazolam;Fentanyl
23 BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX Active, not recruiting NCT02623140 Phase 4
24 Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure Active, not recruiting NCT02797340 Phase 4 Metformin
25 Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS) Completed NCT02824224 Phase 4 Tamoxifen;Placebo (for Tamoxifen)
26 The Treatment of Coronary De-novo Lesions With the Elutax Paclitaxel-eluting Balloon Alone, a Pilot Study Terminated NCT01899235 Phase 4
27 Targeted AntiBiotics for Chronic Obstructive Pulmonary Disease Recruiting NCT03262142 Phase 4 Piperacillin/tazobactam;Ciprofloxacin
28 Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls Completed NCT00115102 Phase 4 fentanyl;S-ketamine
29 The Effect of Calcium and Vitamin D in Patients With Heart Failure Completed NCT00497900 Phase 4 Vitamin D
30 Danish Osteoporosis Prevention Study Completed NCT00252408 Phase 4 Hormone replacement therapy
31 Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients Completed NCT02942550 Phase 4 Methylnaltrexone bromide (Relistor®).;Sodium Chloride 9mg/mL
32 Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children Recruiting NCT03460002 Phase 4
33 Forced Fluid Removal in High Risk Acute Kidney Injury Terminated NCT02458157 Phase 4 Furosemide (Furix)
34 Treatment of Latent Tuberculosis in Socially Marginalised Citizens Recruiting NCT03266991 Phase 4 Rifapentine;Isoniazid
35 Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome Completed NCT00134745 Phase 4 estradiol
36 The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting Not yet recruiting NCT01534221 Phase 4
37 Volatile Anesthetic Protection Of Renal Transplants 2 Recruiting NCT02727296 Phase 4 sevoflurane;propofol
38 Effect of Supplementation With HMB and Glutamine in Wound Healing on Bloody Areas Not yet recruiting NCT03782155 Phase 4 glutamine supplementation;HMB;Placebo
39 Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis Recruiting NCT02831608 Phase 4
40 Treat-to-target With Secukinumab in Axial Spondyloarthritis Recruiting NCT03639740 Phase 4 Secukinumab 150 milligram [Cosentyx]
41 Pan European Collaboration on Antipsychotic Naïve Schizophrenia II Recruiting NCT02339844 Phase 4 Aripiprazole
42 Agents Intervening Against Delirium in Intensive Care Unit Recruiting NCT03392376 Phase 4 Haloperidol Injection
43 Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis Recruiting NCT02308111 Phase 4 Obeticholic Acid (OCA);Placebo
44 Trial for Single Port Versus Conventional Laparoscopic Colectomy Unknown status NCT01101672 Phase 2, Phase 3
45 Morphine, Dyspnea, Exercise and COPD Unknown status NCT01718496 Phase 3 Morphine;Placebo
46 Adjuvant Whole Breast Radiotherapy (RT) With Intensity Modulated Radiotherapy (IMRT) and a Simultaneous Integrated Boost Versus Conventional RT and a Sequential Boost Unknown status NCT01322854 Phase 3
47 Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC Recruiting NCT03348969 Phase 3 Mitomycin c
48 Endo-GIA Versus Endowrist Stapler in Intracorporeal Urinary Diversion in Robotic Assisted Radical Cystectomy Recruiting NCT03385798 Phase 3
49 Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer Not yet recruiting NCT03390413 Phase 3
50 Photodynamic Diagnosis (PDD) in Flexible Cystoscopy Active, not recruiting NCT02660190 Phase 3 hexaminoavolunate

Search NIH Clinical Center for Neuroretinitis

Cochrane evidence based reviews: retinitis

Genetic Tests for Neuroretinitis

Anatomical Context for Neuroretinitis

MalaCards organs/tissues related to Neuroretinitis:

42
Heart, Breast, Brain, Spinal Cord, Testes, Liver, Lung

Publications for Neuroretinitis

Articles related to Neuroretinitis:

(show top 50) (show all 321)
# Title Authors Year
1
Papillitis and neuroretinitis of tuberculous etiology. ( 30718012 )
2019
2
Diffuse unilateral subacute neuroretinitis. ( 30787540 )
2019
3
Toxoplasma Neuroretinitis. ( 30823700 )
2019
4
Idiopathic retinal vasculitis, aneurysms and neuroretinitis (IRVAN): case series of three patients with multimodal imaging. ( 30877369 )
2019
5
Multimodal imaging questions etiology of idiopathic retinal vasculitis, aneurysms and neuroretinitis syndrome (IRVAN syndrome). ( 29406987 )
2018
6
Pathogenesis of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) or 'idiopathic retinal arteriolar aneurysms (IRAA)' with macular star. ( 29447942 )
2018
7
Evolution of a severe case of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) during pregnancy. ( 30389182 )
2018
8
Toxocara Neuroretinitis Associated with Raw Meat Consumption. ( 30405949 )
2018
9
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) in a Patient Without IRVAN History. ( 30419083 )
2018
10
Diffuse Unilateral Subacute Neuroretinitis (DUSN). ( 30578523 )
2018
11
Multimodal Imaging in a Case of Idiopathic Neuroretinitis. ( 30631277 )
2018
12
Case report: a case of diffuse unilateral subacute neuroretinitis (DUSN) in a child. ( 30255794 )
2018
13
Neuroretinitis: a review. ( 30148725 )
2018
14
Molecular diagnosis and ocular imaging of varicella zoster virus associated neuroretinitis. ( 30094392 )
2018
15
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis. ( 30038179 )
2018
16
Resolution of arterial aneurysms in idiopathic retinal vasculitis, aneurysms and neuroretinitis: a case report and review of literature. ( 29594790 )
2018
17
Long-term outcomes in a series of idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome. ( 30340706 )
2018
18
Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? ( 30326075 )
2018
19
A new perspective for analyzing clinical characteristics of idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. ( 29934930 )
2018
20
Recurrent idiopathic neuroretinitis as a spectrum of atypical optic neuritis: a case report and literature review. ( 29538599 )
2018
21
Bilateral neuroretinitis due to Bartonella henselae in a child. ( 29631847 )
2018
22
Bartonella henselaeA neuroretinitis in patients without cat scratch. ( 29962482 )
2018
23
TREATMENT OF IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS, AND NEURORETINITIS (IRVAN) WITH PHOTOCOAGULATION IN COMBINATION WITH SYSTEMIC IMMUNOSUPPRESSION. ( 29261555 )
2017
24
Neuroretinitis Secondary to Bartonella Henselae in a Patient with Myelinated Retinal Nerve Fibers: Diagnostic Dilemmas and Treatment. ( 29283743 )
2017
25
Optical coherence tomography angiography of diffuse unilateral subacute neuroretinitis. ( 29260087 )
2017
26
Full-thickness macular hole: a rare complication of Borrelia burgdorferi neuroretinitis. ( 28473358 )
2017
27
Ultrawide field imaging with navigable magnifier for diagnosis of diffuse unilateral subacute neuroretinitis. ( 29269373 )
2017
28
Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome Presenting With Branch Retinal Artery Occlusion. ( 29121367 )
2017
29
Optical Coherence Tomography in Neuroretinitis: Epipapillary Infiltrates and Retinal Folds. ( 28418948 )
2017
30
Unilateral neuroretinitis. ( 28416231 )
2017
31
A case of suspected symptomatic Zika Neuroretinitis. ( 28736717 )
2017
32
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome: clinical perspectives. ( 29062224 )
2017
33
BARTONELLA HENSELAE NEURORETINITIS ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION, CHOROIDAL ISCHEMIA, AND ISCHEMIC OPTIC NEUROPATHY. ( 28700390 )
2017
34
Diffuse Unilateral Subacute Neuroretinitis Caused by Ancylostoma Hookworm. ( 28098549 )
2017
35
UNILATERAL NEURORETINITIS AS A LATE-ONSET MANIFESTATION OF THE CHIKUNGUNYA FEVER: A CASE SERIES. ( 28957957 )
2017
36
Neuroretinitis as presenting and the only presentation of Lyme disease: Diagnosis and management. ( 28440258 )
2017
37
Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma. ( 27165193 )
2016
38
Bilateral neovascular glaucoma in idiopathic retinal vasculitis, aneurysms, and neuroretinitis syndrome. ( 27085273 )
2016
39
Idiopathic retinal vasculitis, aneurysms and neuroretinitis case report. ( 29503895 )
2016
40
Fluorescein Photodiagnosis of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis (IRVAN) Syndrome: A Case Report and Long-Term Outcome of Photocoagulation Therapy. ( 27491854 )
2016
41
Successful Management of Diffuse Unilateral Subacute Neuroretinitis with Anthelmintics, and Intravitreal Triamcinolone followed by Laser Photocoagulation. ( 27195096 )
2016
42
Toxoplasmosis Neuroretinitis: A Case Report. ( 27340559 )
2016
43
Choroidal neovascularization complicating optic disc drusen, mistaken for Bartonella neuroretinitis. ( 27730317 )
2016
44
Bilateral Neuroretinitis and a Unilateral Superior Hemivein Occlusion with Frosted Branch Angiitis Pattern Presenting Simultaneously in BehAset's Disease. ( 27065852 )
2016
45
Diffuse Unilateral Subacute Neuroretinitis From Raccoon Exposure Resistant to Laser Photocoagulation. ( 27434904 )
2016
46
Vanishing retinal arterial aneurysms with anti-tubercular treatment in a patient presenting with idiopathic retinal vasculitis, aneurysms, and neuroretinitis. ( 26922651 )
2016
47
Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient. ( 27525478 )
2016
48
BARTONELLA QUINTANA-ASSOCIATED NEURORETINITIS: LONGITUDINAL SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHIC FINDINGS. ( 27258542 )
2016
49
An Atypical Presentation of Bartonella Neuroretinitis. ( 26447400 )
2015
50
Systemic Lupus Erythematosus Presenting as Neuroretinitis. ( 27608700 )
2015

Variations for Neuroretinitis

Expression for Neuroretinitis

Search GEO for disease gene expression data for Neuroretinitis.

Pathways for Neuroretinitis

GO Terms for Neuroretinitis

Cellular components related to Neuroretinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 9.02 ACE AQP4 CTLA4 MOG CD274

Biological processes related to Neuroretinitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 kidney development GO:0001822 9.13 ACE CA2 VEGFA
2 positive regulation of peptidyl-tyrosine autophosphorylation GO:1900086 8.62 ACE VEGFA

Sources for Neuroretinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....